Skip to main content
Embecta Corp. logo

Embecta Corp. — Investor Relations & Filings

Ticker · EMBC ISIN · US29082K1051 LEI · 549300RPG8GXVDHNXZ62 US Manufacturing
Open in API
Filings indexed 241 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country US United States of America
Listing US EMBC

About Embecta Corp.

https://www.embecta.com/

Embecta Corp. is a global medical device company focused on improving the health and well-being of people living with diabetes. As one of the largest pure-play diabetes care companies, it leverages a nearly 100-year legacy in insulin delivery. The company's core business involves the manufacturing and distribution of insulin delivery devices, primarily pen needles and insulin syringes, which are used by over 30 million people in more than 100 countries. Embecta is also committed to providing educational resources and support on proper injection techniques to the global diabetes community.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 95% confidence The document is an SEC Form SD “Specialized Disclosure Report” for conflict minerals under Rule 13p-1, which is a specific regulatory filing rather than a full financial report, earnings release, or management presentation. It provides compliance disclosures and exhibits but contains no substantive financial statements. Therefore, it falls under the Regulatory Filings category (RNS) as a miscellaneous SEC form.
2026-05-22 English
CURRENT REPORT
M&A Activity Classification · 90% confidence The document is a U.S. SEC Form 8-K “Current Report” disclosing the completion of an acquisition (Item 2.01 Completion of Acquisition). It is a regulatory announcement of an M&A transaction, which falls under our M&A Activity category, covering announcements/documents related to mergers and acquisitions.
2026-05-15 English
10-Q - Embecta Corp. (0001872789) (Filer)
Interim / Quarterly Report Q2 2026
2026-05-05 English
8-K - Embecta Corp. (0001872789) (Filer)
Report Publication Announcement Classification · 85% confidence The document is a Form 8-K disclosing Item 2.02 “Results of Operations and Financial Condition” and stating that a press release with quarterly results is furnished as Exhibit 99.1. The 8-K itself is short (<5,000 chars) and merely announces that the earnings press release has been published and attached. Under the “menu vs meal” rule, it is an announcement of a report (the press release) rather than the report itself, fitting the Report Publication Announcement (RPA) category.
2026-05-05 English
SCHEDULE 13G/A - Embecta Corp. (0001872789) (Subject)
Major Shareholding Notification
2026-03-26 English
4 Filing
Director's Dealing
2026-02-13 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.